Spectral Medical Inc. - Investor Summit Group

Spectral Medical Inc.

Ticker

EDT

Website

Sector

Healthcare

Tearsheet

Why Invest

Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ (“PMX”.) Spectral, through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new set of proprietary platforms addressing renal replacement therapy (RRT) across the dialysis spectrum.